Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited specializing in medical technology development, has entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda...
To protect their growth in turbidity, Indian pharmaceutical companies, especially the smaller and mid-sized players, are now swinging their attention to...
Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle...
Alembic Pharmaceuticals Limited (Alembic) has received from the U.S. Food and Drug Administration (U.S. FDA), final approval for its ANDA application for...
The Foreign Trade Policy (FTP) 2023's Appendix 2K has been updated by the Directorate General of Foreign Trade (DGFT), requiring pharmaceutical imports and exports to pay a registration fee through the Import Monitoring System (IMS). The objective o
The Union Health Ministry hereby prohibits the use of cold FDC Chlorpheniramine Maleate 2 mg and Phenylephrine Hydrochloride 5 mg per ml drops in children below the...
.png "Venus Remedies' Polymyxin B Gets US FDA QIDP Designation")
The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....
India's pharmaceutical exports to the United States, which amount to nearly $10 billion each year, may face challenges as the US government has commenced an investigation
Amidst the ongoing difficulties in global commerce brought on by US-China tariffs, India's medical equipment industry is seeing a startling increase in imports. Citing the possibility of serious harm to the domestic economy, the Association of Indian
Johnson & Johnson's CEO has cautioned that any US tariffs on the pharmaceutical sector may result in medication shortages. The Trump administration has made it plain that it is considering utilizing the broad tariffs that were announced this month
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
